One of the world’s largest beer manufacturers has initiated three new HIV/Aids prevention projects in Africa.
Heineken has pledged support to expand three existing programmes to help communities where it operates in Nigeria, the Democratic Republic of Congo and South Africa.
It will fund the addition of Nigeria to the PharmAccess African Studies to Evaluate Resistance, which currently monitors HIV drug resistance across six countries across a number of clinics, laboratories and research institutions.
In the DRC, Heineken will support two ‘road clinics’ involved in the provision of health services and education to more than 25,000 transportation employees, while in South Africa the company has pledged to help expand the ongoing King’s Hope Development Foundation project to provide palliative care in areas where it operates.
HIV/Aids forms a key part of the firm’s ‘Brewing a Better Future’ sustainability strategy despite the company, as an beverage manufacturer, having no direct connection to the disease. The newest measures were announced at a HIV symposium hosted by the firm that brought together government figures, NGOs, companies and the public health community.
Heineken chief executive Jean-François van Boxmeer said the three projects ‘will play a small but meaningful role in helping to continue the fight against the disease in Sub-Saharan Africa’.
Heineken has pledged support to expand three existing programmes to help communities where it operates in Nigeria, the Democratic Republic of Congo and South Africa.
It will fund the addition of Nigeria to the PharmAccess African Studies to Evaluate Resistance, which currently monitors HIV drug resistance across six countries across a number of clinics, laboratories and research institutions.
In the DRC, Heineken will support two ‘road clinics’ involved in the provision of health services and education to more than 25,000 transportation employees, while in South Africa the company has pledged to help expand the ongoing King’s Hope Development Foundation project to provide palliative care in areas where it operates.
HIV/Aids forms a key part of the firm’s ‘Brewing a Better Future’ sustainability strategy despite the company, as an beverage manufacturer, having no direct connection to the disease. The newest measures were announced at a HIV symposium hosted by the firm that brought together government figures, NGOs, companies and the public health community.
Heineken chief executive Jean-François van Boxmeer said the three projects ‘will play a small but meaningful role in helping to continue the fight against the disease in Sub-Saharan Africa’.
TriplePundit has published articles from over 1000 contributors. If you'd like to be a guest author, please get in touch!